Poland· PL-100431866
Enterol Forte
A saccharomyces boulardii product containing saccharomyces boulardii cncm i-745, registered in Poland by BIOCODEX. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Saccharomyces boulardii is registered in 10 of 19 countries.
Countries holding a registration under ATC A07FA02 (saccharomyces boulardii), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Saccharomyces boulardii · ATC A07FA02
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of saccharomyces boulardii costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Saccharomyces boulardii · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.16
The record
At a glance
URPL (Poland)- Active substance
- Saccharomyces boulardii CNCM I-745
- Manufacturer
- BIOCODEX
- Country
- Poland (PL)
- ATC code
- A07FA02
- ATC class
- Saccharomyces boulardii
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991486334
- gtin05909991486310
- gtin05909991486327
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A07FA02
Saccharomyces boulardii, as other registers publish it.
- BelgiumAntediar 125 mgWill Pharma
- BelgiumAntediar 250 mgWill Pharma
- United KingdomBiome Balance For those on Antibiotics 300mg capsulesLamberts Healthcare Ltd
- NorwayCodex 5 miliardiBiocodex
- PolandEnterolAllpharm Sp. z o.o. sp.k.
- PolandEnterolDelfarma Sp. z o.o.
- PolandEnterolAllpharm Sp. z o.o. sp.k.
- PolandEnterolInPharm Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3facd33f-bedd-4ae2-92a7-d1852765c1e2 GET /v1/drugs/3facd33f-bedd-4ae2-92a7-d1852765c1e2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania zawiesiny doustnej",
"source": "urpl",
"strength": "500 mg",
"packaging": "05909991486334 ¦ OTC ¦ 143744\n20 sasz. 500 mg\n05909991486310 ¦ OTC ¦ 143745\n14 sasz. 500 mg\n05909991486327 ¦ OTC ¦ 143746\n10 sasz. 500 mg",
"substance": "Saccharomyces boulardii CNCM I-745 500 mg",
"common_name": "Saccharomyces boulardii CNCM I-745",
"pl_product_id": "100431866",
"pozwolenie_nr": "27125",
"auth_procedure": "NAR",
"authorisation_validity": "2027-06-15"
}See everything about saccharomyces boulardii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.